continu
shortag
organ
transplant
limit
number
transplant
year
mani
patient
die
organ
becom
avail
transplant
porcin
organ
becom
increasingli
attract
approach
genom
edit
techniqu
succeed
reduc
reject
rate
transplant
transmiss
infecti
diseas
transplant
alway
concern
allogen
transplant
associ
reactiv
opportunist
infect
recipi
also
infecti
agent
present
donor
tissu
transmit
immunosuppress
case
xenotransplant
transmiss
zoonot
infect
hepat
e
viru
hev
porcin
infecti
agent
might
gain
access
human
host
transplant
addit
present
full
spectrum
infecti
agent
potenti
transmiss
human
host
might
produc
patholog
transplant
porcin
organ
complet
defin
improv
time
go
forward
ensur
safeti
organ
paramount
import
use
highli
sensit
techniqu
detect
potenti
pathogen
help
minim
advers
event
xenotransplant
highli
sensit
method
use
detect
human
virus
transplant
recipi
appli
detect
porcin
virus
pig
recent
notabl
exampl
includ
detect
porcin
cytomegaloviru
pcmv
hepat
e
viru
hev
use
quantit
polymeras
chain
reaction
qpcr
sensit
perform
analyt
method
appear
compar
use
clinic
set
detect
opportunist
infect
human
transplant
recipi
inde
assay
promis
character
porcin
sampl
much
rigor
level
use
qualifi
tissu
human
studi
describ
part
larger
effort
gener
genet
engin
porcin
organ
use
clinic
trial
evalu
potenti
specif
set
target
includ
virus
mycoplasma
speci
select
includ
agent
potenti
impact
health
graft
tissu
potenti
transmit
human
transplant
herein
describ
diagnost
approach
detect
broad
spectrum
infecti
agent
adapt
primer
probe
set
report
literatur
conform
common
amplif
protocol
common
instrument
new
test
regimen
util
detect
target
sow
piglet
deriv
cesarean
section
mani
agent
set
expect
present
distinct
tissu
blood
nasal
swab
stool
swab
evalu
enhanc
detect
data
confirm
presenc
virus
endem
pig
popul
unit
state
approach
use
help
establish
frequenc
mani
infect
herd
final
data
show
piglet
deriv
cesarean
section
infect
agent
detect
sow
deriv
consist
previou
report
valid
infecti
diseas
test
assay
set
posit
control
plasmid
design
synthes
provid
target
sequenc
reaction
descript
sequenc
target
assay
shown
tabl
includ
sequenc
primer
probe
access
number
cognat
agent
genom
coordin
plasmid
contain
multipl
target
well
sequenc
herp
simplex
viru
hsv
facilit
absolut
quantif
plasmid
valid
assay
clinic
laboratori
establish
primer
plasmid
synthes
clone
sequenc
commerci
supplier
yield
qualifi
stock
target
sequenc
integr
dna
technolog
coralvil
ia
target
sequenc
concaten
produc
singl
dna
sequenc
multipl
organ
synthes
clone
pucidt
yield
control
clone
carri
follow
set
target
sequenc
hsv
porcin
circoviru
type
porcin
circoviru
type
porcin
parvoviru
ppv
hsv
noroviru
genogroup
ii
west
nile
viru
wnv
bovin
diarrhea
viru
bvdv
porcin
hemagglutin
encephalomyel
viru
phev
transmiss
gastroenter
viru
tgev
hsv
encephalomyocard
viru
emcv
seneca
valley
viru
sva
porcin
reproduct
respiratori
syndrom
viru
prrv
hsv
hev
reoviru
porcin
lymphotrop
herpesviru
porcin
lymphotrop
herpesviru
hsv
porcin
lymphotrop
herpesviru
porcin
astroviru
astv
sapoviru
sapo
human
influenza
b
viru
ifb
hsv
pcmv
porcin
adenoviru
padv
mycoplasma
haemof
group
mycof
mycoplasma
haemominutum
group
mycom
porcin
endogen
retroviru
c
chikungunya
viru
chikv
hsv
lymphocyt
choriomening
viru
lcmv
rabi
viru
rabv
swine
influenza
ifa
reoviru
reoviru
rotaviru
rota
plasmid
dilut
yield
control
solut
low
copi
number
quantifi
clinic
laboratori
quantit
qpcr
assay
use
measur
viral
load
clinic
specimen
absolut
copi
number
target
dna
solut
adjust
copi
number
plasmid
equival
experiment
confirm
hsv
qpcr
assay
clinic
laboratori
final
control
solut
mix
equimolar
ratio
produc
control
solut
serv
quantit
control
target
describ
possibl
qpcr
assay
report
literatur
perform
report
other
requir
adapt
compat
common
test
platform
use
facilit
parallel
evalu
target
quantstudio
flex
instrument
target
sequenc
adapt
assay
design
within
amplifi
region
report
literatur
least
overlap
sequenc
identifi
refer
cite
tabl
primer
probe
use
studi
shown
tabl
togeth
access
number
nucleotid
sequenc
use
design
primer
genom
coordin
target
well
refer
form
basi
assay
primer
obtain
commerci
supplier
integr
dna
technolog
coralvil
ia
probe
obtain
supplier
fam
fluoresc
dye
intern
zen
iowa
black
quencher
analyt
approach
enabl
parallel
test
target
time
advantag
flexibl
target
detect
addit
primer
probe
set
step
setup
amplif
detect
reaction
perform
biomek
brea
ca
use
reagent
array
plate
fast
pcr
appli
biosystem
reaction
plate
qpcr
briefli
first
reagent
plate
contain
array
primer
probe
set
prepar
water
final
concentr
primer
nmoll
probe
second
reagent
plate
contain
fast
perfecta
qpcr
toughmix
mix
quantabio
beverli
final
reagent
plate
contain
aliquot
water
serv
neg
control
control
plasmid
mixtur
see
posit
control
assay
set
cdna
sampl
serv
templat
see
final
reaction
mixtur
contain
primerprob
mix
polymeras
mix
reaction
buffer
templat
cdna
qpcr
perform
quantstudio
fast
block
appli
biosystem
use
initi
second
denatur
cycl
second
second
result
export
cycl
threshold
ct
valu
use
calcul
copi
number
use
standard
formula
addit
control
includ
intern
control
viru
influenza
b
viru
ifb
spike
specimen
pig
ensur
interf
substanc
sampl
revers
transcript
detect
reaction
perform
accord
specif
intern
control
qpcr
use
detect
control
describ
previous
use
detect
viru
human
clinic
control
qpcr
porcin
cyclophilin
sequenc
genom
dna
also
includ
assay
ensur
integr
sampl
control
experi
perform
method
prescrib
standard
oper
procedur
laboratori
ensur
integr
analyt
method
qualiti
assur
measur
confirm
data
experi
valid
lower
limit
detect
studi
dilut
control
dna
prepar
yield
concentr
rang
copi
per
reaction
copi
number
dilut
control
determin
separ
assay
probit
analysi
use
calcul
lowest
copi
number
could
detect
frequenc
function
varianc
experiment
valu
data
copi
number
control
plasmid
copi
number
experiment
determin
data
enter
graphpad
prism
la
jolla
ca
equat
slope
coeffici
standard
deviat
residu
syx
calcul
probit
analysi
data
perform
excel
evalu
varianc
assay
seri
differ
control
concentr
use
calcul
lower
limit
detect
llod
defin
copi
number
could
detect
assay
reaction
qualit
assay
llod
defin
lowest
copi
number
posit
signal
obtain
separ
determin
second
set
studi
separ
dilut
seri
copi
use
confirm
result
probit
analysi
lower
limit
detect
defin
lowest
concentr
concentr
posit
studi
conform
us
nation
research
council
guid
care
use
laboratori
anim
us
public
health
servic
polici
human
care
use
laboratori
anim
guid
care
use
laboratori
anim
experiment
protocol
use
studi
approv
univers
alabama
birmingham
institut
anim
care
use
committe
recipi
gilt
commerci
landrac
x
larg
white
crossbr
anim
obtain
privatecommerci
farm
gilt
approxim
month
age
gilt
select
normal
gilt
least
two
estrou
record
move
uab
facil
anim
check
health
statu
arriv
farm
recipi
gilt
receiv
vaccin
follow
pathogen
parvoviru
leptospira
erysipela
swine
flu
lawsonia
mycoplasma
circoviru
e
coli
clostridium
rotaviru
anim
locat
room
exclus
dedic
experiment
anim
contact
anim
anim
experiment
group
facil
aalac
certif
fill
hygien
requir
usda
research
speci
piglet
obtain
somat
cell
nuclear
transfer
scnt
produc
research
purpos
piglet
femal
genet
background
landrac
x
yorkshir
piglet
deriv
via
caesarian
section
briefli
inch
incis
made
longitudin
ventromedi
line
last
teat
umbilicu
abdomin
caviti
access
uteru
expos
uterotomi
incis
made
along
uterin
horn
remov
fetus
altern
litter
deriv
hysterectomi
entir
uteru
move
tabl
piglet
harvest
everi
piglet
extract
hand
assist
umbil
cord
clamp
dip
sign
abnorm
record
newborn
move
clean
room
dedic
piglet
piglet
pen
equip
supplement
lamp
heat
neonat
piglet
receiv
mycoplasma
circoviru
vaccin
week
old
piglet
sampl
taken
birth
euthanasia
anim
day
age
specimen
evalu
studi
typic
includ
blood
stool
swab
nasal
swab
vari
depend
harvest
swab
contain
nasal
stool
specimen
ad
standard
viral
transport
media
vtm
supplement
nystatin
gentamycin
mix
ratio
rnalat
invitrogen
carlsbad
ca
blood
specimen
materi
collect
paxgen
blood
rna
tube
thermo
fisher
scientif
waltham
sampl
frozen
prior
transfer
laboratori
analysi
whole
blood
paxgen
tube
invert
mix
store
shipment
receiv
laboratori
sampl
log
store
deidentifi
human
specimen
test
posit
human
virus
obtain
univers
alabama
birmingham
depart
pediatr
molecular
diagnost
laboratori
specimen
type
includ
swab
skin
whole
blood
plasma
nasal
swab
viral
transport
media
dna
rna
extract
use
biorobot
viru
mini
kit
qiagen
briefli
lysi
perform
presenc
proteinas
k
lysi
buffer
ensur
digest
viral
coat
protein
inactiv
rnase
bind
buffer
ad
lysat
mix
magnet
particl
allow
absorpt
viral
nucleic
acid
silica
surfac
contamin
wash
away
sequenc
wash
step
highli
purifi
nucleic
acid
elut
buffer
ave
immedi
store
cdna
could
prepar
stool
sampl
vtm
specimen
suspens
buffer
asl
vortex
incub
room
temp
minut
specimen
heat
minut
nucleic
acid
extract
method
use
nasal
sampl
blood
specimen
total
nucleic
acid
extract
use
viru
mini
kit
biorobot
procedur
essenti
nasal
specimen
blood
specimen
suspend
buffer
atl
vortex
prior
extract
instrument
sampl
revers
transcrib
prior
amplif
detect
target
sequenc
use
high
capac
kit
appli
biosystem
foster
citi
ca
briefli
buffer
enzym
mix
place
reaction
tube
follow
templat
nucleic
acid
reagent
reaction
mixtur
heat
minut
reaction
stop
heat
minut
revers
transcrib
sampl
contain
cdna
store
storag
adapt
primer
probe
set
report
literatur
common
platform
achiev
increas
decreas
length
oligonucleotid
use
primer
probe
target
overlap
amplifi
region
report
approach
result
assay
similar
perform
characterist
evid
similar
assay
perform
paramet
summar
tabl
initi
studi
assay
agent
list
tabl
establish
llod
evalu
seri
control
dna
known
copi
number
assess
sensit
assay
experiment
result
compar
input
copi
number
use
statist
method
calcul
line
assess
linear
sensit
assay
summari
perform
assay
provid
tabl
includ
slope
coeffici
standard
deviat
residu
llod
refer
analyt
assay
data
also
summar
figur
illustr
dynam
rang
linear
reproduc
assay
assay
share
similar
perform
characterist
appear
exhibit
featur
good
quantit
assay
salient
featur
assay
follow
highli
reproduc
standard
deviat
valu
averag
copi
concentr
plasmid
ii
assay
highli
sensit
iii
yield
data
quantit
slope
rang
coeffici
rang
correspond
standard
deviat
residu
valu
iv
assay
prove
quantit
noro
wnv
rota
v
quantit
assay
exhibit
llod
valu
copi
defin
copi
number
could
detect
frequenc
calcul
probit
analysi
confirm
high
level
sensit
second
lower
set
control
plasmid
dilut
prepar
two
three
assay
detect
cognat
sequenc
assay
includ
copi
target
except
lcmv
specimen
detect
copi
data
present
qualit
assay
llod
defin
lowest
concentr
sampl
test
posit
tabl
llod
everi
one
quantit
assay
copi
per
assay
similar
sensit
valid
hsv
assay
use
clinic
specimen
use
document
concentr
control
sensit
hsv
assay
also
determin
platform
use
confirm
accuraci
llod
estim
llod
control
assay
nearli
ident
sensit
determin
clinic
laboratori
valid
plasmid
control
solut
provid
assur
assay
platform
perform
design
data
present
final
assay
noro
wnv
rota
highli
sensit
appear
yield
good
quantit
data
indic
low
coeffici
aberr
slope
valu
tabl
ongo
effort
laboratori
evalu
new
primer
set
hope
improv
assay
ad
addit
target
expect
assay
exhibit
excel
linear
yield
quantit
data
figur
tabl
addit
highli
reproduc
appar
error
bar
shown
figur
three
assay
wnv
rota
noro
highli
sensit
yield
low
slope
valu
elev
standard
deviat
residu
valu
indic
assay
would
gener
quantit
data
thu
consid
qualit
assay
see
figur
e
f
importantli
assay
prove
highli
sensit
llod
virus
copi
per
assay
near
lower
end
rang
tabl
figur
level
sensit
correspond
copiesml
initi
specimen
sensit
compar
well
sensit
hsv
control
assay
document
clinic
laboratori
copyreact
similar
perform
hsv
control
assay
reproduc
assay
platform
interf
substanc
detect
clinic
specimen
evalu
studi
present
intern
control
procedur
place
ensur
consist
perform
assay
data
taken
togeth
support
use
panel
provid
investig
excel
qualit
quantit
inform
target
panel
goal
understand
infecti
diseas
load
normal
healthi
anim
ensur
safeti
porcin
tissu
use
xenotransplant
research
analyt
specif
assay
evalu
use
set
deidentifi
nucleic
acid
specimen
test
posit
human
pathogen
high
viral
load
possibl
specimen
posit
singl
viru
includ
differ
human
herpesvirus
hsv
viru
vzv
human
cytomegaloviru
hcmv
viru
ebv
human
herpesviru
bk
polyomaviru
human
adenoviru
human
enteroviru
tabl
target
detect
analysi
obtain
porcin
cyclophilin
gene
use
detect
host
dna
control
sampl
integr
expect
given
high
level
conserv
pig
human
gene
target
three
nucleotid
base
pair
target
sequenc
differ
porcin
human
gene
also
nucleic
acid
prepar
clinic
laboratori
sampl
spike
influenza
b
viru
consequ
ifb
control
also
neg
expect
notabl
none
assay
porcin
virus
detect
virus
human
specimen
instanc
primer
porcin
herpesvirus
pcmv
amplifi
human
herpesviru
sequenc
specimen
includ
hsv
hcmv
vzv
ebv
even
though
two
specimen
test
contain
copiesml
vzv
hsv
respect
data
confirm
assay
highli
specif
appear
mani
infect
might
expect
occur
human
subject
valid
assay
describ
use
assess
blood
nasal
stool
tissu
specimen
set
adult
anim
piglet
deriv
caesarian
section
data
present
togeth
tabl
overal
studi
perform
well
detect
singl
small
number
specif
target
anim
signal
detect
assay
target
consist
high
specif
assay
describ
specimen
adult
anim
neg
everi
viral
infect
without
regard
statu
two
anim
neg
viral
mycoplasma
target
infect
influenza
rotaviru
parvoviru
circoviru
observ
expect
herd
vaccin
virus
also
consist
data
suggest
highli
specif
assay
common
target
detect
haemotrop
mycoplasma
speci
posit
result
mycoplasma
haemof
group
mycof
anim
posit
test
least
one
specimen
singl
anim
posit
mycoplasma
haemominutum
mycom
group
interest
posit
sampl
studi
detect
blood
specimen
nasal
stool
specimen
gener
neg
studi
sampl
stool
nasal
specimen
detect
blood
specimen
anim
result
confirm
assay
two
group
mycoplasma
highli
specif
suggest
differ
group
haemotrop
mycoplasma
speci
distinct
tissu
unsurpris
mani
anim
infect
mycoplasma
speci
infect
mycoplasma
hyopneumonia
relat
speci
common
infect
gammaherpesvirus
frequent
detect
virus
adult
anim
observ
two
anim
posit
virus
specimen
test
posit
gamma
herpesviru
specimen
posit
indic
assay
specif
distinguish
virus
dna
virus
often
detect
blood
nasal
although
one
stool
specimen
test
posit
anim
also
posit
signal
blood
specimen
result
larg
expect
infect
frequent
detect
feral
domest
hog
mani
geograph
assay
describ
detect
coronavirus
phev
tgev
close
relat
viru
porcin
respiratori
coronaviru
prcv
well
porcin
epidem
diarrhea
viru
pedv
specimen
test
anim
describ
obtain
summer
month
none
test
posit
virus
howev
phev
detect
adult
anim
specimen
obtain
winter
respiratori
season
data
present
unexpect
frequent
detect
domest
anim
assay
detect
target
sequenc
adult
anim
posit
specimen
includ
blood
nasal
stool
sampl
two
anim
level
within
order
magnitud
pcyp
control
might
indic
assay
detect
integr
sequenc
third
anim
level
detect
low
order
magnitud
lower
pcyp
control
contrast
result
adult
anim
piglet
deliv
caesarian
section
neg
target
test
except
singl
posit
nasal
specimen
posit
mycoplasma
haemof
group
tabl
result
consist
result
adult
anim
target
detect
often
stool
nasal
specimen
one
notabl
result
three
separ
set
piglet
deriv
sow
detect
yet
none
piglet
appear
infect
viru
one
sow
also
infect
yet
appear
transmit
either
viru
piglet
deliv
caesarian
section
result
confirm
vertic
transmiss
agent
ineffici
confirm
also
procedur
use
deriv
piglet
could
also
minim
transmiss
virus
singl
anim
tabl
piglet
yield
posit
result
three
separ
virus
includ
influenza
viru
reoviru
rotaviru
result
trigger
investig
coinfect
three
viral
agent
unusu
specimen
repeat
target
detect
determin
fals
posit
result
test
pig
specimen
indic
assay
perform
well
typic
detect
small
number
target
nucleic
acid
expect
also
show
piglet
deriv
caesarian
section
typic
neg
target
detect
sow
deriv
data
consist
high
specif
observ
assay
typic
singl
small
number
specif
target
detect
signal
detect
larg
major
assay
fact
specimen
neg
viral
target
specimen
piglet
test
neg
viral
target
except
singl
sow
test
neg
target
specimen
infect
influenza
rotaviru
parvoviru
circoviru
detect
adult
anim
expect
vaccin
virus
common
infecti
agent
detect
data
present
speci
haemotrop
mycoplasma
group
adult
anim
test
neg
sampl
type
assay
report
previous
two
major
group
mycoplasma
also
appear
highli
specif
anim
infect
either
one
two
group
interest
mycoplasma
haemominutum
group
detect
blood
specimen
mycoplasma
haemof
group
detect
nasal
stool
specimen
also
confirm
specif
assay
unsurpris
mani
anim
infect
mycoplasma
speci
infect
mycoplasma
hypopneumonia
relat
speci
common
infect
gammaherpesvirus
frequent
detect
virus
sow
observ
dna
detect
blood
nasal
specimen
includ
one
anim
posit
signal
blood
nasal
specimen
anim
infect
one
anim
posit
blood
nasal
second
posit
blood
third
anim
posit
blood
stool
total
specimen
test
anim
two
posit
virus
suggest
assay
distinguish
virus
also
consist
high
specif
describ
assay
tabl
infect
virus
frequent
detect
feral
domest
hog
mani
geograph
data
also
consist
human
data
gamma
herpesviru
ebv
human
popul
worldwid
carri
viru
persist
infect
viru
remain
latent
b
cell
easili
detect
pcr
even
healthi
interest
sow
test
posit
appear
transmit
viru
piglet
deriv
caesarian
section
number
small
transmiss
detect
three
sow
infect
piglet
deriv
caesarian
section
similarli
singl
sow
fail
transmit
piglet
also
deriv
caesarian
section
data
appear
suggest
procedur
use
deriv
piglet
effici
prevent
transmiss
virus
possibl
infect
might
becom
appar
piglet
test
later
life
somewhat
surpris
betaherpesviru
pcmv
detect
sow
test
although
assay
detect
viru
subsequ
specimen
adult
pig
pcmv
common
infect
pig
mani
part
world
expertli
review
viru
close
relat
human
roseolavirus
great
major
pig
herd
seroposit
howev
infect
rate
us
report
much
lower
countri
one
possibl
reason
dna
experiment
primari
infect
pcmv
result
congenit
infect
mani
piglet
confirm
transplacent
potenti
infect
distinct
human
roseolaviru
infect
transmit
congenit
live
birth
without
appar
symptom
infant
although
integr
host
genom
make
detect
congenit
infect
import
remain
mind
potenti
transmiss
porcin
herpesvirus
alphaherpesviru
suid
herpesviru
human
anecdot
report
literatur
seem
suggest
transmiss
inde
possibl
yet
signific
barrier
human
infect
like
potenti
transmiss
betaherpesviru
pcmv
human
cell
also
investig
limit
avail
reagent
thu
far
prevent
unequivoc
document
porcin
gammaherpesvirus
also
might
potenti
transmit
human
coinfect
cell
ebv
might
factor
mutual
transactiv
virus
isol
sow
pregnanc
combin
cesarean
deliveri
rigor
test
regimen
presenc
viru
nucleic
acid
transgen
piglet
minim
potenti
transmiss
virus
piglet
analyt
approach
describ
evalu
infect
assay
detect
four
coronavirus
import
mani
coronavirus
cross
speci
barrier
readili
caus
zoonot
virus
detect
assay
describ
includ
porcin
hemagglutin
encephalomyel
viru
phev
transmiss
gastroenter
viru
tgev
close
relat
viru
porcin
respiratori
well
porcin
epidem
diarrhea
viru
pedv
none
sow
describ
test
posit
coronaviru
unsurpris
specimen
collect
summer
month
infect
would
expect
less
frequent
subsequ
test
assay
detect
betacoronaviru
phev
specimen
collect
winter
month
consist
report
show
frequent
detect
domest
anim
viru
common
infect
swine
mani
countri
includ
unit
state
relat
circul
human
coronavirus
thu
far
alphacoronaviru
infect
detect
includ
pedv
tgev
porcin
respiratori
coronaviru
target
swine
hepat
e
detect
specimen
notwithstand
use
assay
report
highli
sensit
swine
hepat
e
viru
potenti
infect
human
describ
excel
recent
go
forward
critic
monitor
sow
particularli
piglet
ensur
transplant
tissu
remain
free
studi
present
limit
avail
pig
specimen
test
posit
laboratori
infecti
agent
describ
also
limit
rel
small
number
anim
describ
detail
report
howev
subsequ
evalu
addit
specimen
result
detect
target
includ
sva
noro
ifa
phev
prr
rota
bvdv
pcmv
padv
mycof
mycom
specimen
spike
emcv
detect
target
pig
specimen
provid
reassur
analyt
method
function
design
priori
reason
target
might
difficult
detect
other
method
describ
importantli
data
data
tabl
also
help
document
analyt
specif
assay
infecti
diseas
panel
porcin
specimen
specimen
evalu
separ
assay
differ
virus
parallel
detect
one
posit
target
typic
occur
togeth
neg
result
remain
target
ideal
assay
valid
process
would
similar
use
assay
human
virus
clinic
use
describ
report
clinic
continu
effort
evalu
larg
number
porcin
specimen
expect
yield
posit
sampl
target
valuabl
reagent
valid
studi
continu
sensit
assay
describ
compar
favor
sensit
describ
similar
assay
describ
pcmv
sensit
copyreact
report
similar
copiesreact
report
hev
sensit
copiesreact
report
similar
genom
equivalentsreact
report
sensit
qpcr
assay
use
mani
differ
laboratori
like
similar
adopt
intern
standard
world
health
organ
would
help
make
direct
comparison
possibl
futur
nonetheless
high
sensit
analyt
specif
assay
describ
suggest
perform
least
well
describ
previou
report
discuss
assay
describ
select
design
provid
parallel
evalu
compar
larg
set
target
select
help
minim
risk
diseas
transmiss
xenotransplant
set
assay
larg
autom
possibl
individu
evalu
least
specimen
per
day
panel
assay
could
also
easili
multiplex
addit
differ
fluoresc
label
probe
code
sequenc
primer
flexibl
approach
afford
import
move
forward
inform
potenti
risk
improv
target
ad
set
agent
describ
work
nonetheless
panel
report
herein
promis
provid
data
enhanc
safeti
porcin
tissu
xenotransplant
also
valuabl
evalu
human
specimen
follow
xenotransplant
